Skip to main content
Sign In
 

Thomas P. Beresford, MD

Professor


​Contact Info:

Veterans Administration Medical Center

EmailDr. Beresford 


Clinical/Research Interests:

Dr. Beresford is interested in conducting research on substance dependence and the physiological responses to psychopharmacological treatments.

 

Stanford University  BA  1969

University of Colorado  MD  1973

Boston College  MA  1978​

Ad Hoc Reviewer, Metabolic Pathology Study Section, NIH, 1992-84 

Ad Hoc Reviewer, Metabolic Pathology Study Section, NIH, 2007-09 
SOM representative, University Planning and Accreditation Committee, UCD, 2008-present  ​ 

Selected Peer-Reviewed Publications:

1.  Beresford, T.P., Low, D., Hall, R.C.W.:  Patients Who Refuse Study:  A Bias Factor In Alcoholism Prevalence Research.  Current Controversies in Alcoholism, 2:17-22, 1983.

2.  Beresford, T.P., et al:  Comparison of CAGE Questionnaire and Computer-Assisted Laboratory Profiles in Screening for Covert Alcoholism, The Lancet.  (336), 482-485, 1990.

3.  Beresford TP, et al:  When is an Alcoholic an Alcoholic, Alc & Alcism, Suppl.1:487-488, 1991.

4.  McCurry, KR, Baliga, P, Merion, RM, Ham, JM, Lucey, MR, Beresford, TP, Campbell, DA:  Liver Transplantation For Alcoholic Cirrhosis:  Resource Utilization and Outcome.  Archives of Surgery, 1992.

5.  Lucey, MR, Merion, RM, Henley, KS, Campbell, DS, Nostrant, TT, Blow, FC, and Beresford TP.  The Selection For and Outcome Of Liver Transplant in Alcoholic Liver Disease.  Gastroenterology, 1992.

6.  Beresford, TP, Wilson, D, Schwarz, et al:  The Short-term Psychological Health of Alcoholic and Non-alcoholic Liver Transplant Recipients.  Alcoholism: Clin and Exp Research, 16: 996-1000, 1992

7.   Schwarz, J, Speed, N, Gross, M, Beresford, TP:  Acute Effects Of Alcohol Administration On Regional Cerebral Blood Flow.  Alcoholism: Clinical and Experimental Research, 1993.

8.  Lucey, ML, Beresford, TP: Can We Triage Alcoholics With Liver Disease? Am J Gastro 88: 1314-5, 1993.

9.  Lucey, MR, Merion, RM, Beresford, TP: Liver Trans and the Alc Patient, Cambridge,Cambr U Press 1994.

10.  Beresford, T.P, Lucey, M.R.  Alcoholics and Liver Transplant: Facts, Biases. Addiction, 89:1043-48, 1994.

11.  Beresford TP: Predictive Factors For Alcoholic Relapse In the Selection of Alcohol Dependent Persons For Hepatic Transplant, Liver Transplantation and Surgery, 3: 280-291, 1997.

12. Lucey, MR, Carr, K, Beresford, TP et al: Alcohol Use After Liver Transplantation In Alcoholics:  a Clinical Cohort Follow-up Study, Hepatology, 25: 1223-1227, 1997.

13. Lucey, MR, Demo-Dananberg, L, Young, J, Hill, E, Beresford, TP.  The Influence of Age and Sex on Ethanol Metabolism in Healthy Humans. Journal of Studies on Alcohol, 60:  103-110, 1999.

14. Stallings, MC, Hewitt, JK, Beresford, T, Heath, AC, & Eaves, LJ. A twin study of drinking and smoking onset and latencies from first use to regular use. Behavior Genetics, 29(6): 409-421, 1999.

15. Beresford, TP, Arciniegas, D, Rojas, D, et al.  Hippocampal To Pituitary Volume Ratio:  a Specific Measure Of Reciprocal Neuroendocrine Alterations In Alcohol Dependence. J Stud Alc, 60:586-8, 1999.

16. Bridgeford, D., Arciniegas, D.B., Batkis, M., Sandberg, E., Beresford, T.P.  Methylphenidate Treatment Of Neuropsychiatric Symptoms Of Central And Extrapontine Myelinolysis. J Stud on Alc,  61:657-60, 2000.

17. Arciniegas, D and Beresford, TP: Neuropsychiatry. Cambridge, Cambridge University Press, 2001.

18.  Beresford, T.  Neuropsychiatric Complications of Liver Transplant.  Liver Transplant., 7:S36-45, 2001.

19. Martin, B, Clapp, L, Bridgeford, D, Amponsah, A, Bialkowski, D, Lyons, L, Beresford, TP. Compliance With Supervised Disulfiram:  Voluntary and Court-Ordered Patients. Am J Addictions.12:137-143, 2003

20. Beresford,  T., Martin B, Alfers, J. Developing a Brief Monitoring Procedure for Alcohol Dependent Liver Graft Recipients. Psychosomatics. 45(3):220-3, 2004.

21. Martin, B, Clapp, L, Beresford, TP. Adherence to Court-Ordered Disulfiram At Fifteen Months: A Naturalistic Study. Journal of Substance Abuse Treatment, 26: 233-236, 2004.

22. Clapp L, Martin B, Beresford TP.Sublingual cocaine:novel recurrence. J CLin Neuropharm.,27:93-4, 2004.

23. Martin, B, Alfers, J, Kulig, C, Clapp, L, Bialkowski, D, Bridgeford, D, Beresford, TP. Disulfiram therapy in patients with hepatitis-C: a 12-month, controlled, follow-up study. J Studies Alcohol, 65(5): 651-657, 2004.

24. Beresford, TP, Arciniegas, D, Clapp, L, et al. Reduction of affective lability and alcohol use following traumatic brain injury: anti-convulsant medications. Brain Injury. 19: 309-313, 2005.

25. Kulig, C, Beresford, TP.  Hepatitis C In Alcohol Dependence: disulfiram. J of Addict Dis, 24: 77-89, 2005.

26. Martin, B, Mangum, L, Beresford, TP. Use of Court-Ordered Supervised Disulfiram Therapy at DVA Medical Centers in the United States. American Journal on Addictions. 14(3): 208-212. 2005

27. Beresford, H.F., Deitrich, R., Beresford, T.P. Cyclosporin-A discourages Ethanol Intake in C57bl/6j mice: a preliminary study. Journal of Studies on Alcohol. 66: 1-5, 2005

28. Beresford, TP, Alfers, J, Mangum, L, et al.  Cancer Survival As a Function of Psychological Adaptation Mechanisms Versus Depressive Symptoms.  Psychosomatics, 47:247-53, 2006

29. Beresford, TP, Arciniegas, DB, Alfers, et al.   Hippocampus Volume Loss Due to Chronic Heavy Drinking.  Alcoholism: Clinical and Experimental Research, 30:  1866-1870, 2006.

30. Beresford, TP, Arciniegas, DB, Alfers, J, et al.   Hypercortisolism In Alcohol Dependence and Its Relation to Hippocampal Volume Loss.  Journal of Studies on Alcohol, 67: 861-867, 2006.

31. Morfin JP, Kulig CC, Braddock AL, Everson GT, and Beresford TP.  Normalization for Albumin Increases FAEE correlation with Blood Ethanol.  Alcoholism: Clin Exp Research, 31:  265-268, 2007.

32. Kahn, R, … Beresford, T, et al.  Multi-Center Trial of Baclofen for Abstinence Initiation in Severe Cocaine Dependent Individuals, Drug Alcohol Dependence, 103: 59-64, 2009.

Recent Grants and Contracts:

1) “Neuro-immunophyllin Ligand Mechanism of Action in Reducing Alcohol Preference”

Principal Investigator: Thomas P. Beresford, M.D.

NIH/NIAAA:  R21, $315,000 total, 12/01/08 – 11/30/10

 

2) “A Double Blind Trial of Divalproex Sodium for Affective Lability and Alcohol Use Following Traumatic Brain Injury” 

Principal Investigator:  Thomas P. Beresford, M.D.

CDMRP, Department of Defense:  PT075168; period 9/15/08-9/14/2012. $755,994 total

 

3) “Aripiprazole in Co-morbid Schizophrenia and Cocaine Dependent Patients”

Principal Investigator: Thomas P. Beresford, M.D.

Bristol Myers Squibb: Investigator Initiated Study, $253,900 total, period: 8/1/08 – 7/31/10